IPO registrations (S-1, F-1) · Registrants
FENNEC PHARMACEUTICALS INC.
- SEC CIK
- 1211583 · filings on EDGAR ↗
- Former names
- ADHEREX TECHNOLOGIES INC (2002–2014)
- Registration
- Form S-1, first filed 2010-11-12, last 2017-08-31; 4 initial registrations, 2 amendments
- Outcome
- Declared effective 2011-02-11; withdrawal requested 2016-04-11
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- A1
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, Research Triangle Park, NC 27709
- Ticker
- FENC (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- FENNEC PHARMACEUTICALS INC. on the corporate pages
Offering terms
- Shares offered
- 11,943,214
- Listing
- TSX under the symbol FRX
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: FENNEC PHARMACEUTICALS, INC. Fuzzy (name and state)
- Federal award recipient: FENNEC PHARMACEUTICALS, INC. Fuzzy (name and state)
- Form D issuer: FENNEC PHARMACEUTICALS INC. EXACT (CIK (EXACT))
- SEC filer: ADHEREX TECHNOLOGIES INC EXACT (CIK (EXACT))
- Person page: Chris A Rallis Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Fred H Mermelstein Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: James E Besser Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
Filings 15
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2010-11-12 | S-1 | S-1 (registration) | ADHEREX TECHNOLOGIES INC | 0001144204-10-059734 ↗ |
| 2011-02-09 | S-1/A | S-1/A (amendment) | ADHEREX TECHNOLOGIES INC | 0001144204-11-007025 ↗ |
| 2011-02-11 | EFFECT | EFFECT (declared effective) | ADHEREX TECHNOLOGIES INC | 9999999995-11-000423 ↗ |
| 2011-11-10 | EFFECT | EFFECT (declared effective) | ADHEREX TECHNOLOGIES INC | 9999999995-11-003219 ↗ |
| 2013-04-03 | EFFECT | EFFECT (declared effective) | ADHEREX TECHNOLOGIES INC | 9999999995-13-000867 ↗ |
| 2014-04-18 | EFFECT | EFFECT (declared effective) | ADHEREX TECHNOLOGIES INC | 9999999995-14-001043 ↗ |
| 2014-05-09 | S-1 | S-1 (registration) | ADHEREX TECHNOLOGIES INC | 0001144204-14-028928 ↗ |
| 2014-05-14 | EFFECT | EFFECT (declared effective) | ADHEREX TECHNOLOGIES INC | 9999999995-14-001483 ↗ |
| 2015-05-12 | S-1 | S-1 (registration) | FENNEC PHARMACEUTICALS INC. | 0001144204-15-029745 ↗ |
| 2016-04-11 | RW | RW (withdrawal request) | FENNEC PHARMACEUTICALS INC. | 0001144204-16-093693 ↗ |
| 2017-08-10 | S-1 | S-1 (registration) | FENNEC PHARMACEUTICALS INC. | 0001144204-17-042100 ↗ |
| 2017-08-31 | S-1/A | S-1/A (amendment) | FENNEC PHARMACEUTICALS INC. | 0001144204-17-046095 ↗ |
| 2017-09-18 | EFFECT | EFFECT (declared effective) | FENNEC PHARMACEUTICALS INC. | 9999999995-17-002381 ↗ |
| 2017-11-03 | EFFECT | EFFECT (declared effective) | FENNEC PHARMACEUTICALS INC. | 9999999995-17-002860 ↗ |
| 2018-04-19 | EFFECT | EFFECT (declared effective) | FENNEC PHARMACEUTICALS INC. | 9999999995-18-000862 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-08-31 | S-1/A | registration statement | $1.90 | 11,943,214 | $22,692,106 | TSX FRX | 0 | primary document; price sentence, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Butts Robert W | Director; Director,Officer,TenPercentOwner; Director,TenPercentOwner; TenPercentOwner | Chairman of Board | 5 | 2007–2010 | |
| Clark John Smith II | TenPercentOwner | 12 | 2007–2025 | ||
| Southpoint Capital Advisors LLC | TenPercentOwner | 12 | 2007–2025 | ||
| Southpoint Capital Advisors LP | TenPercentOwner | 12 | 2007–2025 | ||
| Southpoint GP, LLC | TenPercentOwner | 12 | 2007–2025 | ||
| Southpoint GP, LP | TenPercentOwner | 12 | 2007–2025 | ||
| KLEIN JAMES A JR | Officer | CFO | 5 | 2007–2008 | |
| KUFE DONALD W | Director | 4 | 2007 | ||
| MARTIN MICHAEL G | Director | 3 | 2007 | ||
| Mermelstein Fred H | Director | 3 | 2007 | person page Fuzzy | |
| MORAND PETER | Director | 3 | 2007 | ||
| MURRAY D SCOTT | Officer | SVP, Gen Counsel & Corp Secty | 5 | 2007–2008 | |
| NORRIS ROBIN J | Director,Officer; Officer | President; President & COO | 6 | 2007–2009 | |
| Peters William P | Director,Officer | Chairman and CEO | 4 | 2007–2008 | |
| PORTER ARTHUR T | Director | 4 | 2007–2010 | ||
| SOLASH JEFFREY | Officer | Chief Licensing Officer | 1 | 2007 | |
| BREEN WILLIAM G | Director | 4 | 2007–2010 | ||
| BUSSANDRI CLAUDIO F | Director | 4 | 2007–2010 | ||
| Andrade Robert | Director,Officer; Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER; NA; Vice President | 58 | 2009–2026 | |
| Raykov Rosty | Director; Director,Officer; Officer; Other | Chief Executive Officer; CHIEF EXECUTIVE OFFICER; NA | 72 | 2009–2026 | |
| Spector Thomas | Officer | Chief Scientific Officer; NA | 2 | 2009–2010 | |
| Lieberman David B. | Director | 1 | 2011 | ||
| BESSER JAMES E | TenPercentOwner | 9 | 2013–2018 | person page Fuzzy | |
| FRANK MORGAN C. | TenPercentOwner | 9 | 2013–2018 | ||
| Manchester Explorer, L.P. | TenPercentOwner | 9 | 2013–2018 | ||
| MANCHESTER MANAGEMENT CO LLC | TenPercentOwner | 9 | 2013–2018 | ||
| Southpoint Master Fund, LP | TenPercentOwner | 1 | 2017 | ||
| Brughera Marco Maria | Director | 11 | 2017–2026 | ||
| Haigh Adrian | Director; Officer | CHIEF OPERATING OFFICER | 14 | 2017–2024 | |
| RALLIS CHRIS A | Director | 33 | 2017–2026 | person page Fuzzy | |
| Essetifin SPA | TenPercentOwner | 4 | 2017–2020 | ||
| Islam Khalid | Director | 11 | 2017–2026 | ||
| Cavazza Enrico | TenPercentOwner | 3 | 2017–2020 | ||
| Cavazza Francesca | TenPercentOwner | 3 | 2017–2020 | ||
| CAVAZZA PAOLO | TenPercentOwner | 3 | 2017–2020 | ||
| Cavazza Preta Martina | TenPercentOwner | 3 | 2017–2020 | ||
| Cavazza Silvia | TenPercentOwner | 3 | 2017–2020 | ||
| MANCHESTER MANAGEMENT PR, LLC | TenPercentOwner | 5 | 2018 | ||
| Goel Shubh | Officer | Chief Commercial Officer | 5 | 2019–2021 | |
| Cook Jodi A | Director | 9 | 2019–2026 | ||
| Hackman Jeffrey S. | Director,Officer | Chief Executive Officer | 12 | 2024–2026 | |
| Cioffi Christiana Marie | Officer | Chief Strategy Officer | 11 | 2024–2026 | |
| Evans Terry L | Officer | Chief Commercial Officer | 10 | 2024–2026 | |
| Sayad Pierre Sargis | Officer | Chief Medical Officer | 9 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2017-06-08 | FENNEC PHARMACEUTICALS INC. | Biotechnology | $7,600,000 | $7,600,000 | 7 | 1 |
| 2014-12-15 | FENNEC PHARMACEUTICALS INC. | Biotechnology | $2,200,000 | $2,200,000 | 22 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | FENNEC PHARMACEUTICALS, INC. | NC | State business registries | name and state |
| Plan sponsor | FENNEC PHARMACEUTICALS | NC | Form 5500 (employee benefit plans) | name and state |
| Federal award recipient | FENNEC PHARMACEUTICALS, INC. | NC | Federal spending (USAspending) | name and state |
| Form D issuer | FENNEC PHARMACEUTICALS INC. | NC | Form D private offerings | CIK (EXACT) |
| Paying company | Fennec Pharmaceuticals, Inc. | NC | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Fennec Pharmaceuticals, Inc. | NC | Patents (USPTO) | name and state |
| SEC filer | FENNEC PHARMACEUTICALS INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Fennec Pharmaceuticals, Inc. | NC | Trademarks (USPTO) | name and state |
| Person page | Chris A Rallis | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Fred H Mermelstein | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | James E Besser | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), NC first:
- ALDAGEN INC NC
- TENGION INC NC
- Chelsea Therapeutics International, Ltd. NC
- AERIE PHARMACEUTICALS INC NC
- PRECISION BIOSCIENCES INC NC
- Axium Pharmaceuticals Inc. NC
- Immunovant, Inc. NC
- Humacyte, Inc. NC
- PROKIDNEY CORP. NC
- Pelthos Therapeutics Inc. NC
In other datasets, the same topic (Health) in NC:
- Nonprofit: 24 FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health